|

Esketamine group Clinical Trials

1 actively recruiting trial

Also known as: Spravato®

Pipeline

Phase 4: 1

Top Sponsors

  • The George Institute1

Indications

  • Treatment-resistant Depression1
  • Depression1

Other1 trial

Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.